Evaluation of Pre- and Posttransplantation Serum Interferon-Gamma and Soluble CD30 for Predicting Liver Allograft Rejection

Transplantation Proceedings

Volumn 38, Issue 5, 2006, Pages 1429-1431

  Kim, K H ^a   Oh, E J ^b   Jung, E S ^b   Park, Y J ^b   Choi, J Y ^b   Kim, D G ^b   Lee, K Y ^b   Kang, C S ^b  

^a Seoul National University   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD30 ANTIGEN; CYCLOSPORIN; CYTOKINE; GAMMA INTERFERON; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ARTICLE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; LIVER GRAFT; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANTIGENS, CD; ANTIGENS, CD30; BIOLOGICAL MARKERS; GRAFT REJECTION; HUMANS; INTERFERON TYPE II; LIVER TRANSPLANTATION; LIVING DONORS; POSTOPERATIVE PERIOD; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; TH2 CELLS;

EID: 33745190457     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.03.032     Document Type: Article

References (8)

1. Platz K.P., Mueller A.R., Rossaint R., et al. Cytokine pattern during rejection and infection after liver transplantation-improvements in postoperative monitoring?. Transplantation 62 (1996) 1441
2. Tilg H., Vogel W., Aulitzky W.E., et al. Evaluation of cytokines and cytokine-induced secondary messages in sera of patients after liver transplantation. Transplantation 49 (1990) 1074
3. Wang Y.L., Tang Z.Q., Gao W., et al. Influence of Th1, Th2, and Th3 cytokines during the early phase after liver transplantation. Transplant Proc 35 (2003) 3024
4. Durkop H., Latza U., Hummel M., et al. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68 (1992) 421
5. Susal C., Pelzl S., Simon T., et al. Advances in pre- and posttransplant immunologic testing in kidney transplantation. Transplant Proc 36 (2004) 29
6. Pelzl S., Opelz G., Daniel V., et al. Evaluation of posttransplantation soluble CD30 for diagnosis of acute renal allograft rejection. Transplantation 75 (2003) 421
7. Slavcev A., Lacha J., Honsova E., et al. Soluble CD30 and HLA antibodies as potential risk factors for kidney transplant rejection. Transpl Immunol 14 (2005) 117
8. Yamamoto S., Sato Y., Ichida T., et al. Can serum cytokine levels during the early postoperative period predict acute cellular rejection episodes?. Transplant Proc 35 (2003) 253